- Home
- BFRI vs ABVC Comparison
BFRI vs ABVC Comparison
Compare BFRI & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- ABVC
- Stock Information
- Founded
- BFRI 1997
- ABVC 2015
- Country
- BFRI United States
- ABVC United States
- Employees
- BFRI N/A
- ABVC N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- BFRI Health Care
- ABVC Health Care
- Exchange
- BFRI Nasdaq
- ABVC Nasdaq
- Market Cap
- BFRI 6.2M
- ABVC 6.5M
- IPO Year
- BFRI 2021
- ABVC N/A
- Fundamental
- Price
- BFRI $0.98
- ABVC $0.52
- Analyst Decision
- BFRI Strong Buy
- ABVC
- Analyst Count
- BFRI 1
- ABVC 0
- Target Price
- BFRI $7.00
- ABVC N/A
- AVG Volume (30 Days)
- BFRI 990.2K
- ABVC 373.8K
- Earning Date
- BFRI 11-13-2024
- ABVC 11-14-2024
- Dividend Yield
- BFRI N/A
- ABVC N/A
- EPS Growth
- BFRI N/A
- ABVC N/A
- EPS
- BFRI N/A
- ABVC N/A
- Revenue
- BFRI $35,358,000.00
- ABVC $509,788.00
- Revenue This Year
- BFRI $17.69
- ABVC N/A
- Revenue Next Year
- BFRI $19.71
- ABVC N/A
- P/E Ratio
- BFRI N/A
- ABVC N/A
- Revenue Growth
- BFRI 5.17
- ABVC N/A
- 52 Week Low
- BFRI $0.61
- ABVC $0.41
- 52 Week High
- BFRI $3.90
- ABVC $2.45
- Technical
- Relative Strength Index (RSI)
- BFRI 52.63
- ABVC 45.32
- Support Level
- BFRI $0.94
- ABVC $0.46
- Resistance Level
- BFRI $1.06
- ABVC $0.54
- Average True Range (ATR)
- BFRI 0.12
- ABVC 0.04
- MACD
- BFRI -0.01
- ABVC 0.00
- Stochastic Oscillator
- BFRI 28.89
- ABVC 64.07
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.